ADVANCING SCIENCE. ENHANCING VISION.
Live / Registered — Registered — Section 8 accepted (as of 21 Apr 2022)
What this means for you
Registered since 20 Oct 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 85318930
- Registration number
- 4834268
- Mark type
- Stylized text
- Filed
- 12 May 2011
- Published for opposition
- 04 Aug 2015
- Registered
- 20 Oct 2015
- Attorney of record
- Clifford D. Hyra
Goods and services
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research and design of new products in the field of ophthalmic, visual, vascular, [ cardiac, ] inflammation, [ hypertension, immune system, blood and cancer ] disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention, and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; industrial research analysis and product research services in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder detection, in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder prevention and in the field of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer disease and disorder treatment; pharmaceutical, biopharmaceutical, medical, biomedical, biological, biochemical, toxicological and clinical research, namely, conducting clinical trials for others or providing consultancy services to others for conducting clinical trials, and product development of diagnostic tests and kits, biopharmaceutical preparations and drugs, and medicines; biopharmaceutical product evaluation; biological, biochemical, pharmaceutical, medical, toxicological and clinical research, namely, conducting clinical trials for others or providing consultancy services to others for conducting clinical trials, and scientific research for medical purposes in the treatment of ophthalmic, visual, vascular, cardiac, inflammation, hypertension, immune system, blood and cancer diseases and disorders; development services in the field of new biopharmaceutical drugs, preparations and medicines for ophthalmic, vascular and cancer pathologies
Owner
- OXURION, HEVERLEE, BE
- ThromboGenics NV, Heverlee, BE
- ThromboGenics NV, Heverlee, BE
- ThromboGenics NV, Heverlee, BE
Prosecution history
- 20 Oct 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 23 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Dec 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 23 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Apr 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 21 Apr 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 14 Apr 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Oct 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 20 Oct 2021 — TEAS SECTION 8 RECEIVED
- 20 Oct 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Oct 2015 — REGISTERED-PRINCIPAL REGISTER
- 04 Aug 2015 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Aug 2015 — PUBLISHED FOR OPPOSITION
- 15 Jul 2015 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED